Clinical Laserthermia Systems AB (FRA:LS60) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


FRA:LS60 Clinical Laserthermia Systems AB FRA:LS60
36 GF Score
Price €0.27
GF Value €0.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Clinical Laserthermia Systems AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:LS60 vs ABT, SYK, MDT: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Clinical Laserthermia Systems AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinical Laserthermia Systems AB Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Clinical Laserthermia Systems AB's Margin of Safety % (DCF FCF Based) falls into.


FRA:LS60
36GF Score
Clinical Laserthermia Systems AB FRA:LS60
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of €0.27 is trading 7.9% below its estimated GF Value™ of €0.29. GuruFocus considers Clinical Laserthermia Systems AB to be Fairly Valued.

Key valuation signals for FRA:LS60:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €0.29 vs. price of €0.27 (7.9% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinical Laserthermia Systems AB Business Description

Other Exchanges CLS B:Sweden
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
36GF Score

Get the complete analysis for FRA:LS60

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.29
GF Value